Bristol-Myers Squibb Company has announced plans to acquire privately-held Amira Pharmaceuticals Inc of San Diego, California, paying $325 million upfront, in order to expand its portfolio into potential treatments for fibrotic diseases. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
